Theseus Pharmaceuticals, Inc.
THRXDelisted Feb 14, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001745020
Theseus Pharmaceuticals, Inc. was delisted on Feb 14, 2024; its insiders filed their last Form 4 on Feb 14, 2024; 70 institutions reported holding it in 13F filings for Q4 2023, worth $145.8M in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Theseus Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 63
- −5 vs. Q2 2023
- Shares held
- 35.3M
- −4.67M (−11.7%) vs. Q2 2023
- Total value
- $95.5M
- −$277.5M (−74.4%) vs. Q2 2023
- New holders
- 10
- 19 more added
- Sold out
- 15
- 21 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting THRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 70 | $145.8M |
| Q3 2023 | 63 | $95.5M |
| Q2 2023 | 69 | $373.6M |
| Q1 2023 | 72 | $350.6M |
| Q4 2022 | 47 | $164.8M |
| Q3 2022 | 51 | $200.7M |
| Q2 2022 | 51 | $191.6M |
| Q1 2022 | 47 | $402.8M |
| Q4 2021 | 46 | $441.4M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Theseus Pharmaceuticals, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 15 | $40 | 0.00% | −6,014−99.8% | Reduced |
| Glassman Wealth Services | 241 | $648 | 0.00% | +241 | New |
| Red Tortoise LLC | 536 | $1.44K | 0.00% | +536 | New |
| FMR LLC | 755 | $2.03K | 0.00% | −804,886−99.9% | Reduced |
| Deutsche Bank AG | 870 | $2.34K | 0.00% | −7,104−89.1% | Reduced |
| Ameritas Investment Partners, Inc. | 889 | $2.39K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,796 | $5.00K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 1,930 | $5.19K | 0.00% | 00.0% | Unchanged |
| STRS Ohio | 2,700 | $7.00K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,793 | $7.51K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 4,466 | $12.0K | 0.00% | −2,266−33.7% | Reduced |
| Wells Fargo & Company | 4,981 | $13.4K | 0.00% | −2,728−35.4% | Reduced |
| Tower Research Capital LLC (TRC) | 5,734 | $15.4K | 0.00% | +5,036+721.5% | Added |
| Royal Bank of Canada | 6,756 | $18.0K | 0.00% | +4,644+219.9% | Added |
| Barclays PLC | 7,832 | $21.1K | 0.00% | −533−6.4% | Reduced |
| New York State Common Retirement Fund | 9,606 | $25.8K | 0.00% | +72+0.8% | Added |
| American International Group, Inc. | 10,100 | $27.2K | 0.00% | +359+3.7% | Added |
| American Century Companies Inc | 10,514 | $28.3K | 0.00% | +10,514 | New |
| Principal Financial Group Inc | 10,679 | $28.7K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 10,750 | $28.9K | 0.00% | +6,520+154.1% | Added |
| Susquehanna International Group, LLP | 11,112 | $29.9K | 0.00% | +11,112 | New |
| Two Sigma Advisers, LP | 12,200 | $32.8K | 0.00% | −18,000−59.6% | Reduced |
| JPMorgan Chase & Co | 13,141 | $35.3K | 0.00% | −2,572−16.4% | Reduced |
| Alliancebernstein L.P. | 15,620 | $42.0K | 0.00% | −202,858−92.9% | Reduced |
| Bank of America Corp | 17,415 | $46.8K | 0.00% | +13,413+335.2% | Added |
| Forefront Analytics, LLC | 17,672 | $47.5K | 0.03% | +17,672 | New |
| Squarepoint Ops LLC | 19,653 | $52.9K | 0.00% | +19,653 | New |
| Two Sigma Investments, LP | 22,651 | $60.9K | 0.00% | −29,150−56.3% | Reduced |
| Prelude Capital Management, LLC | 27,073 | $72.8K | 0.01% | +27,073 | New |
| Rhumbline Advisers | 27,958 | $75.2K | 0.00% | +661+2.4% | Added |
| Walleye Capital LLC | 31,998 | $86.1K | 0.00% | +31,998 | New |
| Exchange Traded Concepts, LLC | 36,210 | $97.4K | 0.00% | +21,419+144.8% | Added |
| Gsa Capital Partners LLP | 36,587 | $98.0K | 0.01% | +36,587 | New |
| Morgan Stanley | 38,570 | $103.8K | 0.00% | −1,407−3.5% | Reduced |
| Dimensional Fund Advisors LP | 46,153 | $124.2K | 0.00% | −32,840−41.6% | Reduced |
| Charles Schwab Investment Management Inc | 56,203 | $151.2K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 59,553 | $160.2K | 0.00% | 00.0% | Unchanged |
| Manufacturers Life Insurance Company, The | 79,751 | $214.5K | 0.00% | −8,130−9.3% | Reduced |
| Renaissance Technologies LLC | 126,194 | $339.0K | 0.00% | +84,994+206.3% | Added |
| Denali Advisors LLC | 127,900 | $344.1K | 0.12% | +111,400+675.2% | Added |
| Ensign Peak Advisors, Inc | 139,196 | $374.4K | 0.00% | −3,402−2.4% | Reduced |
| Boxer Capital, LLC | 150,000 | $403.5K | 0.02% | −200,000−57.1% | Reduced |
| Northern Trust Corp | 157,325 | $423.2K | 0.00% | −6,790−4.1% | Reduced |
| Laurion Capital Management LP | 171,157 | $460.4K | 0.01% | −8,462−4.7% | Reduced |
| UBS Oconnor LLC | 181,452 | $488.1K | 0.01% | +60,000+49.4% | Added |
| TD Asset Management Inc | 213,896 | $575.4K | 0.00% | +106,948+100.0% | Added |
| Driehaus Capital Management LLC | 232,693 | $625.9K | 0.01% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 259,470 | $696.0K | 0.00% | +259,470 | New |
| Nuveen Asset Management, LLC | 81,898 | $779.7K | 0.00% | −580−0.7% | Reduced |
| State Street Corp | 368,660 | $991.7K | 0.00% | +1,144+0.3% | Added |
| Affinity Asset Advisors, LLC | 400,726 | $1.08M | 0.35% | +160,482+66.8% | Added |
| Geode Capital Management, LLC | 405,578 | $1.09M | 0.00% | −15,944−3.8% | Reduced |
| Rock Springs Capital Management LP | 437,329 | $1.18M | 0.03% | 00.0% | Unchanged |
| Nextech Invest AG | 611,310 | $1.64M | 0.50% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 702,415 | $1.89M | 1.25% | −54,594−7.2% | Reduced |
| Omega Fund Management, LLC | 711,479 | $1.91M | 1.76% | 00.0% | Unchanged |
| Vanguard Group Inc | 789,120 | $2.12M | 0.00% | +57,695+7.9% | Added |
| Price T Rowe Associates Inc | 1,216,500 | $3.27M | 0.00% | −39,509−3.1% | Reduced |
| BlackRock Inc. | 1,340,480 | $3.61M | 0.00% | +6,612+0.5% | Added |
| Millennium Management LLC | 1,717,862 | $4.62M | 0.00% | +1,588,867+1,231.7% | Added |
| Frazier Life Sciences Management, L.P. | 2,248,194 | $6.05M | 0.40% | 00.0% | Unchanged |
| Foresite Capital Management V, LLC | 4,108,796 | $11.1M | 17.63% | +523,450+14.6% | Added |
| OrbiMed Advisors LLC | 17,713,600 | $47.6M | 1.10% | +479,932+2.8% | Added |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −1,950,327−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −1,400,352−100.0% | Sold out |
| VR Adviser, LLC | 0 | $0 | 0.00% | −770,000−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −633,423−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −604,550−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −597,500−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −277,074−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −270,015−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −153,673−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −136,719−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −28,941−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −10,330−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −1,126−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −163−100.0% | Sold out |
| Tekla Capital Management LLC | – | – | – | – | Not filed |